Mariam Wael

Pharos Holding

Equity Research Analyst @ Pharos Holding

Mariam is an Equity Research Analyst at Pharos Holding, focusing on the Egyptian market. She holds a bachelor's degree – majoring in Finance and minoring in Financial Economics. 

Mariam Wael
Hide filters Show filters
Latest articles from Mariam Wael

Telecom Egypt: Healthy revenue growth drives profitability and margin expansion

ETEL reported 1Q21 revenues of EGP8.40 billion, compared to EGP7.00 billion in 1Q20 and EGP9.56 billion in 4Q20 (+19.9% YoY, -12.2% QoQ). Home fixed voice revenues showed a notable growth as well of 21.1% YoY and 11.0% QoQ. Annual increase is attribu...
Pharos Holding Mariam
Mariam Wael @ Pharos Holding 11 May 2021

Rameda Pharmaceuticals: Covid-related antivirals support sales growth but pressure margins

According to IQVIA, retail pharma sales recorded EGP6.75 billion and EGP6.14 billion in January and February 2021, an increase of 14% and 5% YoY, according to the latest available data. During 1Q21, RMDA’s private sales recorded EGP170 million (+12.7...
Pharos Holding Mariam
Mariam Wael @ Pharos Holding 11 May 2021

Cleopatra Hospitals Group: Strong rebound in 4Q20 paves the way for a better 2021, Maintain Overweight

Annual volumes remain lower than 2019 levels, where total number of patients served in 2020 recorded 902.57k, which is a decline of 11% YoY, on the back of 2Q20 hit driven by covid-19 implications. Polyclincs recorded revenues of EGP24 million in 4Q2...
Pharos Holding Mariam
Mariam Wael @ Pharos Holding 21 March 2021

MM Group: Muted revenue growth; E-payments business is mostly priced in

On a quarterly basis, 4Q20 consolidated revenues came in at EGP2.13 billion (+1.6% YoY, -3.5% QoQ), driven by a solid rebound in Kanawat’s revenues (+60.8% YoY, +20.2% QoQ) and held back by weak automotive sales (-36.0% YoY, +24.1% QoQ). Kanawat, sho...
Pharos Holding Mariam
Mariam Wael @ Pharos Holding 14 March 2021

Rameda Pharmaceuticals: Solid sequential recovery and interest income boost performance

During 2021, we expect the retail pharma market to record sales of EGP87.3 billion (+8.8% YoY) and non-retail pharma sales to record EGP41.3 billion (+7.1% YoY), bringing total pharma sales to EGP128.6 billion, up from EGP116.1 billion in 2020e, with...
Pharos Holding Mariam
Mariam Wael @ Pharos Holding 2 March 2021

ISPH: 4Q20 – A relatively weak quarter

According to ISPH data, retail pharma sales recorded EGP78.6 billion in 2020, an increase of 5% YoY, compared to a growth rate of 17.7% in 2019. ISPH reported 4Q20 net revenues of EGP4.98 billion, compared to EGP4.67 billion in 4Q19, and compared to ...
Pharos Holding Mariam
Mariam Wael @ Pharos Holding 1 March 2021

Filter by tags

Egypt
Africa
Mariam Wael
MENA
Equity
2021
Communication Services
2020
2019
Media & Entertainment
Vodafone
Telecom Egypt
1Q20
ETEL

Contact Mariam

Description